Also trades as: GN.CO (CPH) · $vol 9M · GGNDF (OTC) · $vol 0M

$47.62

-1.12 (-2.30%)

Weekly Expected Move ±5.9%

$42 $45 $48 $50 $53

OTC · Healthcare · Medical - Devices · Tech Score Buy · Power 66 · $2.3B mcap · 48M float · 0.0011% daily turnover · Short 50% of daily vol

Revenue

$16.8B -6.7% ▼

5Y CAGR: +4.5%

Gross Profit

$9.2B -4.3% ▼

5Y CAGR: +4.6%

Operating Income

$1.6B -14.2% ▼

5Y CAGR: -0.4%

Net Income

$653M -33.9% ▼

5Y CAGR: -12.2%

EPS (Diluted)

$12.93 -36.4% ▼

5Y CAGR: -14.9%

EBITDA

$2.6B -15.2% ▼

5Y CAGR: -0.5%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$15.8B	$18.7B	$18.1B	$18.0B	$16.8B
YoY Growth	+17.3%	+18.5%	-3.0%	-0.7%	-6.7%
Cost of Revenue	$7.1B	$9.6B	$9.1B	$8.4B	$7.6B
Gross Profit	$8.7B	$9.1B	$9.0B	$9.6B	$9.2B
Gross Margin	55.0%	48.9%	49.9%	53.2%	54.6%
R&D Expenses	$1.4B	$1.4B	$1.5B	$1.5B	$1.5B
SG&A Expenses	$4.7B	$6.2B	$5.8B	$2.4B	$2.3B
Operating Expenses	$6.3B	$8.0B	$8.2B	$7.7B	$7.6B
Operating Income	$2.4B	$1.1B	$869M	$1.9B	$1.6B
Operating Margin	15.2%	5.9%	4.8%	10.3%	9.5%
Interest Expense	$91M	$186M	$326M	$379M	$620M
Income Before Tax	$2.3B	$725M	$343M	$1.4B	$914M
Tax Expense	$481M	$155M	$77M	$302M	$204M
Net Income	$1.8B	$511M	$228M	$988M	$653M
Net Margin	11.1%	2.7%	1.3%	5.5%	3.9%
EPS (Diluted)	$40.47	$11.97	$4.92	$20.34	$12.93
EBITDA	$3.5B	$2.4B	$2.4B	$3.1B	$2.6B
Shares Outstanding	43M	43M	46M	49M	49M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$4.2B	$5.0B	$4.0B	$4.2B	$3.9B	$4.7B	$2.1B	$2.2B
Cost of Revenue	$1.9B	$2.3B	$1.8B	$1.8B	$1.9B	$2.1B	$1.1B	$1.1B
Gross Profit	$2.3B	$2.7B	$2.2B	$2.3B	$2.1B	$2.5B	$1.0B	$1.1B
Gross Margin	54.8%	53.2%	54.9%	55.6%	52.0%	53.4%	48.2%	49.5%
R&D Expenses	$343M	$355M	$373M	$344M	$317M	$421M	$617M	$224M
SG&A Expenses	$1.4B	-$1.9B	$1.5B	$1.4B	$1.4B	-$2.0B	$792M	$805M
Operating Expenses	$1.8B	$2.1B	$2.0B	$1.9B	$1.7B	$2.0B	$1.5B	$1.1B
Operating Income	$516M	$601M	$215M	$460M	$331M	$561M	-$472M	-$16M
Operating Margin	12.4%	12.0%	5.4%	11.1%	8.4%	12.0%	-22.5%	-0.7%
Interest Expense	$145M	$87M	$228M	$297M	$253M	$293M	$188M	$291M
Income Before Tax	$371M	$503M	$114M	$232M	$118M	$446M	-$561M	-$281M
Tax Expense	$82M	$111M	$25M	$52M	$27M	$100M	-$124M	$63M
Net Income	$271M	$367M	$71M	$165M	$73M	$344M	-$955M	-$22M
Net Margin	6.5%	7.3%	1.8%	4.0%	1.8%	7.4%	-45.6%	-1.0%
EPS (Diluted)	$5.58	$7.56	$1.47	$3.39	$1.50	$7.02	$-19.68	$-0.45
EBITDA	$774M	$875M	$681M	$807M	$712M	$454M	$1.2B	$240M
Shares Outstanding	49M	49M	49M	49M	49M	49M	49M	49M

GNNDY OTC